Reduced expression of NF-AT and NF-kappa B transcription factors in tolerant recipients treated with tolerogenic allochimeric donor/recipient class I MHC protein.
Akioka
K
K
Division of Immunology and Organ Transplantation, University of Texas Medical School at Houston 77030, USA.
Kirkin
R
R
Wang
M
M
Tian
L
L
Yu
J
J
Stepkowski
S M
SM
Kahan
B D
BD
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D005786:Gene Expression Regulation / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000627:therapeutic use*; D015395:Histocompatibility Antigens Class I / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods*; D017710:Lymphocyte Transfusion; D008285:Major Histocompatibility Complex; D008297:Male; D016328:NF-kappa B / Q000235:genetics*; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D051381:Rats; D011912:Rats, Inbred ACI; D011920:Rats, Inbred WF; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology*; D014157:Transcription Factors / Q000235:genetics*; D014158:Transcription, Genetic
D016207:Cytokines; D004268:DNA-Binding Proteins; D006649:Histocompatibility Antigens; D015395:Histocompatibility Antigens Class I; D016328:NF-kappa B; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D011993:Recombinant Fusion Proteins; D014157:Transcription Factors; C038353:histocompatibility antigens RT, rat; D016572:Cyclosporine